Chaloulos-Iakovidis, Panagiotis; Aicher, Marie Louise; Chilver-Stainer, Lara (2021). [An Unusual Cause for a Bilateral Ptosis]. Praxis, 110(11), pp. 643-646. Hogrefe 10.1024/1661-8157/a003706
Text
Chaloulos__2021__Ungew_hnliche_Ursache.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (182kB) |
An Unusual Cause for a Bilateral Ptosis Abstract. Immune-checkpoint-inhibitors are increasingly used in various malignancies. Autoimmune side effects such as colitis, hepatitis or skin reactions are well known, on the other hand neurological autoimmune complications such as myasthenic syndromes, myopathies or overlap syndromes with potentially life-threatening complications are less common and not well understood. A precise diagnosis has far reaching therapeutic consequences. Here we present the case of a patient under immune checkpoint inhibitor therapy, in which the diagnosis, due to the presence of overlap symptoms, is shown to be challenging. However, it was crucial to find the correct diagnosis in order to choose the proper therapy.
Item Type: |
Journal Article (Further Contribution) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Chaloulos-Iakovidis, Panagiotis, Chilver-Stainer, Lara |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1661-8157 |
Publisher: |
Hogrefe |
Language: |
German |
Submitter: |
Chantal Kottler |
Date Deposited: |
23 Nov 2021 13:46 |
Last Modified: |
05 Dec 2022 15:54 |
Publisher DOI: |
10.1024/1661-8157/a003706 |
PubMed ID: |
34465196 |
Uncontrolled Keywords: |
Bilateral ptosis Bilaterale Ptose Immun-Checkpoint-Inhibitor-Therapie Myasthenia gravis Myositis Pembrolizumab immune checkpoint therapy myasthenia gravis myositis pembrolizumab |
BORIS DOI: |
10.48350/160826 |
URI: |
https://boris.unibe.ch/id/eprint/160826 |